癌症患者随机启动的体外受精(IVF)周期的IVF特征和分子黄体特征与传统周期并无差异。
IVF characteristics and the molecular luteal features of random start IVF cycles are not different from conventional cycles in cancer patients.
作者信息
Esmaeilian Yashar, Hela Francesko, Bildik Gamze, Akin Nazli, İltumur Ece, Yusufoglu Sevgi, Yildiz Ceren Sultan, Keles İpek, Vatansever Dogan, Taskiran Cagatay, Yakin Kayhan, Oktem Ozgur
机构信息
Research Center for Translational Medicine, Koç University, Istanbul, Turkey.
The Graduate School of Health Sciences, Koç University, Istanbul, Turkey.
出版信息
Hum Reprod. 2023 Jan 5;38(1):113-124. doi: 10.1093/humrep/deac242.
STUDY QUESTION
Are the IVF parameters and the steroidogenic luteal characteristics of random-start IVF cycles different from conventional cycles in cancer patients?
SUMMARY ANSWER
No; controlled ovarian stimulation cycles randomly started at late follicular phase (LFP) and luteal phase (LP) are totally comparable to those conventional IVF cycles started at early follicular phase (EFP) in terms of the expression of the enzymes involved in cholesterol utilization and steroid hormone biosynthesis pathways, gonadotropin receptor expression and, estradiol (E2) and progesterone (P4) production in addition to the similarities in ovarian response to gonadotropin stimulation, oocyte yield, fertilization rate and embryo development competency in cancer patients.
WHAT IS KNOWN ALREADY
Random start ovarian stimulation protocols are commonly employed for oocyte and embryo freezing for fertility preservation in cancer patients with time constraints who do not have sufficient time to undergo ovarian stimulation initiated conventionally at EFP of the next cycle. No data is available regarding the molecular steroidogenic features of these cycles analyzed together with the clinical IVF characteristics in cancer patients. We aimed to address this question in this study to help understand how similar the random start cycles are to the conventional start ones.
STUDY DESIGN, SIZE, DURATION: A clinical translational research study conducted in 62 cancer patients undergoing IVF for fertility preservation between the years 2017 and 2022.
PARTICIPANTS/MATERIALS, SETTING, METHODS: Sixty-two patients who were diagnosed with different types of cancer and underwent ovarian stimulation for oocyte (n = 41) and embryo (n = 21) cryopreservation using GnRH antagonist protocol and human menopausal gonadotropins before receiving cancer treatment/surgery were enrolled in the study. For patients with breast cancer and endometrial cancer the aromatase inhibitor letrozole was used with gonadotropin stimulation. Ovarian stimulation was initiated conventionally at EFP in 22 patients and served as control while it was started at LFP in 20, and mid-LP in the other 20 patients. The luteinized granulosa cells (GCs) were recovered from follicular aspirates during oocyte retrieval procedure and used for the experiments separately for each individual patient. The expression of the enzymes involved in sex steroid biosynthesis (StAR, 3β-HSD, Aromatase) and cholesterol synthesis (3-hydroxy 3-methylglutaryl Co-A reductase (HMG-Co-A reductase)), utilization (hormone sensitive lipase (HSL)), and storage (Acetyl-Coenzyme A acetyltransferase 1 (ACAT-1)), and gonadotropin receptor expression status were analyzed using immunoblotting and RT-PCR methods. Laser confocal immunofluorescence imaging was applied to analyze and compare the expression patterns of the steroidogenic enzymes and their relation with mitochondria. In vitro E2 and P4 production by the cells were compared among the groups.
MAIN RESULTS AND THE ROLE OF CHANCE
Baseline demographic and IVF characteristics of the patients undergoing the conventional start and random start IVF cycles were similar. Duration of gonadotropin stimulation was significantly longer in LFP and LP start cycles in comparison to the conventional ones. Ovarian response to gonadotropin stimulation, mature and total oocyte yield, fertilization and Day 5 blastulation rates of the embryos were comparable between the conventional versus random start cycles. When the luteal GCs of these random start cycles were analyzed we could not find any gross differences between these cycles in terms of the viability index and gross light microscopic morphologic features. More detailed analysis of the molecular luteal characteristics of the cells using RT-PCR, immunoblotting methods revealed that the expression profiles of the gonadotropin receptors, and the enzymes involved in sex steroid biosynthesis and cholesterol synthesis/utilization, and the steroidogenic activity of the luteal GCs of the random start cycles are almost identical to those of the conventional start cycles. Confocal image analysis demonstrated similar patterns in the signal expression profiles of the steroidogenic enzymes and their co-localization within mitochondria.
LARGE SCALE DATA
N/A.
LIMITATIONS, REASONS FOR CAUTION: Caution should be exercised when interpreting our data and counseling cancer patients seeking fertility preservation because it is still unclear if previous exposure to cancer drugs, different ovarian pathologies or infertility etiologies, previous ovarian surgery and/or any other underlying diseases that are concomitantly present with cancer may cause a difference between conventional and random start stimulation protocols in terms of IVF parameters, luteal function and reproductive outcome. Relatively low number of patients in each stimulation protocol and pooling of luteal GCs for each patient rather than individual analysis of each follicle and oocyte are additional limitations of our study.
WIDER IMPLICATIONS OF THE FINDINGS
Our findings provide reassurance that random start protocol offers cancer patients an equally good prospect of fertility preservation as conventional IVF.
STUDY FUNDING/COMPETING INTEREST(S): Funded by the School of Medicine, the Graduate School of Health Sciences of Koc University and Koç University Research Center for Translational Medicine (KUTTAM), equally funded by the Republic of Turkey Ministry of Development Research Infrastructure Support Program. All authors declare no conflict of interest.
TRIAL REGISTRATION NUMBER
N/A.
研究问题
癌症患者随机启动的体外受精(IVF)周期的IVF参数和类固醇生成黄体特征与传统周期是否不同?
总结答案
否;在晚期卵泡期(LFP)和黄体期(LP)随机启动的控制性卵巢刺激周期,在胆固醇利用和类固醇激素生物合成途径中涉及的酶的表达、促性腺激素受体表达、雌二醇(E2)和孕酮(P4)产生方面,与在早期卵泡期(EFP)启动的传统IVF周期完全可比,此外在癌症患者中,卵巢对促性腺激素刺激的反应、卵母细胞产量、受精率和胚胎发育能力也相似。
已知信息
随机启动卵巢刺激方案通常用于癌症患者的卵母细胞和胚胎冷冻以保存生育能力,这些患者由于时间限制没有足够时间接受在下一周期EFP常规启动的卵巢刺激。目前尚无关于这些周期的分子类固醇生成特征与癌症患者临床IVF特征一起分析的数据。我们旨在通过本研究解决这个问题,以帮助了解随机启动周期与传统启动周期的相似程度。
研究设计、规模、持续时间:2017年至2022年间对62例接受IVF以保存生育能力的癌症患者进行的一项临床转化研究。
参与者/材料、设置、方法:62例被诊断为不同类型癌症且在接受癌症治疗/手术前使用GnRH拮抗剂方案和人绝经期促性腺激素进行卵巢刺激以冷冻卵母细胞(n = 41)和胚胎(n = 21)的患者纳入研究。对于乳腺癌和子宫内膜癌患者,芳香化酶抑制剂来曲唑与促性腺激素刺激联合使用。22例患者在EFP常规启动卵巢刺激并作为对照,20例在LFP启动,另外20例在LP中期启动。在卵母细胞采集过程中从卵泡抽吸物中回收黄体化颗粒细胞(GCs),并分别用于每个患者的实验。使用免疫印迹和RT-PCR方法分析参与性类固醇生物合成(StAR、3β-HSD、芳香化酶)和胆固醇合成(3-羟基-3-甲基戊二酰辅酶A还原酶(HMG-CoA还原酶))、利用(激素敏感脂肪酶(HSL))和储存(乙酰辅酶A乙酰转移酶1(ACAT-1))的酶的表达,以及促性腺激素受体表达状态。应用激光共聚焦免疫荧光成像分析和比较类固醇生成酶的表达模式及其与线粒体的关系。比较各组细胞的体外E2和P4产生。
主要结果及机遇的作用
接受传统启动和随机启动IVF周期的患者的基线人口统计学和IVF特征相似。与传统周期相比,LFP和LP启动周期的促性腺激素刺激持续时间明显更长。传统启动与随机启动周期之间,卵巢对促性腺激素刺激的反应、成熟和总卵母细胞产量、胚胎的受精和第5天囊胚形成率相当。当分析这些随机启动周期的黄体GCs时,我们发现在活力指数和大体光学显微镜形态特征方面,这些周期之间没有任何明显差异。使用RT-PCR、免疫印迹方法对细胞的分子黄体特征进行更详细分析发现,随机启动周期的促性腺激素受体、参与性类固醇生物合成和胆固醇合成/利用的酶的表达谱,以及黄体GCs的类固醇生成活性与传统启动周期几乎相同。共聚焦图像分析显示类固醇生成酶的信号表达谱及其在线粒体内的共定位模式相似。
大规模数据
无。
局限性、谨慎理由:在解释我们的数据和为寻求生育力保存的癌症患者提供咨询时应谨慎,因为目前尚不清楚先前接触癌症药物、不同的卵巢病理或不孕病因、先前的卵巢手术和/或与癌症同时存在的任何其他基础疾病是否可能在IVF参数、黄体功能和生殖结局方面导致传统启动和随机启动刺激方案之间存在差异。每个刺激方案中的患者数量相对较少,并且对每个患者的黄体GCs进行汇总而非对每个卵泡和卵母细胞进行单独分析是我们研究的其他局限性。
研究结果的更广泛影响
我们的研究结果提供了保证,即随机启动方案为癌症患者提供了与传统IVF同样良好的生育力保存前景。
研究资金/利益冲突:由科克大学医学院、健康科学研究生院和科克大学转化医学研究中心(KUTTAM)资助,由土耳其共和国发展部研究基础设施支持计划同等资助。所有作者均声明无利益冲突。
试验注册号
无。